Publication
Severe hyponatremia following low-dose cyclophosphamide in a patient with breast cancer: a case report.
Çiğdem Cindoğlu, Fatma Zehra Ağan
International cancer conference journalOct 1, 2026PMID 42781081doi:10.1007/s13691-026-00908-9 PMC13597999Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260926-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Cyclophosphamide is a commonly used alkylating chemotherapy agent in the treatment of neoadjuvant, adjuvant, and metastatic breast cancer. Sudden onset, symptomatic, and severe hyponatremia (defined as serum sodium < 125 mmol/L) is a rare but potentially life-threatening complication associated…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Breast Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.